These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19440048)

  • 21. Pancreatic ductal adenocarcinoma cells employ integrin α6β4 to form hemidesmosomes and regulate cell proliferation.
    Humphries JD; Zha J; Burns J; Askari JA; Below CR; Chastney MR; Jones MC; Mironov A; Knight D; O'Reilly DA; Dunne MJ; Garrod DR; Jorgensen C; Humphries MJ
    Matrix Biol; 2022 Jun; 110():16-39. PubMed ID: 35405272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic jetlag accelerates pancreatic neoplasia in conditional
    Schwartz PB; Walcheck MT; Nukaya M; Pavelec DM; Matkowskyj KA; Ronnekleiv-Kelly SM
    Chronobiol Int; 2023 Apr; 40(4):417-437. PubMed ID: 36912021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multilevel Regulation of NF-κB Signaling by NSD2 Suppresses Kras-Driven Pancreatic Tumorigenesis.
    Feng W; Niu N; Lu P; Chen Z; Rao H; Zhang W; Ma C; Liu C; Xu Y; Gao WQ; Xue J; Li L
    Adv Sci (Weinh); 2024 Aug; 11(30):e2309387. PubMed ID: 38889281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development.
    Shankar S; Tien JC; Siebenaler RF; Chugh S; Dommeti VL; Zelenka-Wang S; Wang XM; Apel IJ; Waninger J; Eyunni S; Xu A; Mody M; Goodrum A; Zhang Y; Tesmer JJ; Mannan R; Cao X; Vats P; Pitchiaya S; Ellison SJ; Shi J; Kumar-Sinha C; Crawford HC; Chinnaiyan AM
    Nat Commun; 2020 Jun; 11(1):2817. PubMed ID: 32499547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Target-Specific Nanoparticle Polyplex Down-Regulates Mutant
    Smith JP; Chen W; Shivapurkar N; Gerber M; Tucker RD; Kallakury B; Dasa SSK; Kularatne RN; Stern ST
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS.
    Duan X; Zhang T; Feng L; de Silva N; Greenspun B; Wang X; Moyer J; Martin ML; Chandwani R; Elemento O; Leach SD; Evans T; Chen S; Pan FC
    Cell Stem Cell; 2024 Jan; 31(1):71-88.e8. PubMed ID: 38151022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axl-mediated activation of TBK1 drives epithelial plasticity in pancreatic cancer.
    Cruz VH; Arner EN; Du W; Bremauntz AE; Brekken RA
    JCI Insight; 2019 Apr; 5(9):. PubMed ID: 30938713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers.
    Ozkan-Dagliyan I; Diehl JN; George SD; Schaefer A; Papke B; Klotz-Noack K; Waters AM; Goodwin CM; Gautam P; Pierobon M; Peng S; Gilbert TSK; Lin KH; Dagliyan O; Wennerberg K; Petricoin EF; Tran NL; Bhagwat SV; Tiu RV; Peng SB; Herring LE; Graves LM; Sers C; Wood KC; Cox AD; Der CJ
    Cell Rep; 2020 Jun; 31(11):107764. PubMed ID: 32553168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early elevations of RAS protein level and activity are critical for the development of PDAC in the context of inflammation.
    Ma J; Gong F; Kim E; Du JX; Leung C; Song Q; Logsdon CD; Luo Y; Li X; Lu W
    Cancer Lett; 2024 Apr; 586():216694. PubMed ID: 38307409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pan-KRAS inhibitors suppress proliferation through feedback regulation in pancreatic ductal adenocarcinoma.
    Wang CX; Wang TT; Zhang KD; Li MY; Shen QC; Lu SY; Zhang J
    Acta Pharmacol Sin; 2022 Oct; 43(10):2696-2708. PubMed ID: 35352018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic dependency plays a dominant role in the immune response to cancer.
    Li J; D'Amico S; Kirillov V; Petrenko O; Reich NC
    Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2308635120. PubMed ID: 37782788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma.
    Gulay KCM; Zhang X; Pantazopoulou V; Patel J; Esparza E; Pran Babu DS; Ogawa S; Weitz J; Ng I; Mose ES; Pu M; Engle DD; Lowy AM; Tiriac H
    Cancer Res; 2023 Sep; 83(18):3001-3012. PubMed ID: 37378556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers.
    Klomp JA; Klomp JE; Stalnecker CA; Bryant KL; Edwards AC; Drizyte-Miller K; Hibshman PS; Diehl JN; Lee YS; Morales AJ; Taylor KE; Peng S; Tran NL; Herring LE; Prevatte AW; Barker NK; Hover LD; Hallin J; Sorokin A; Kanikarla PM; Chowdhury S; Coker O; Lee HM; Goodwin CM; Gautam P; Olson P; Christensen JG; Shen JP; Kopetz S; Graves LM; Lim KH; Wang-Gillam A; Wennerberg K; Cox AD; Der CJ
    Science; 2024 Jun; 384(6700):eadk0775. PubMed ID: 38843331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice.
    Kimura K; Satoh K; Kanno A; Hamada S; Hirota M; Endoh M; Masamune A; Shimosegawa T
    Cancer Sci; 2007 Feb; 98(2):155-62. PubMed ID: 17297654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression.
    Zhang H; Sun Y; Wang Z; Huang X; Tang L; Jiang K; Jin X
    Nat Commun; 2024 May; 15(1):4642. PubMed ID: 38821916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sphingosine is involved in PAPTP-induced death of pancreas cancer cells by interfering with mitochondrial functions.
    Patel SH; Wilson GC; Wu Y; Keitsch S; Wilker B; Mattarei A; Ahmad SA; Szabo I; Gulbins E
    J Mol Med (Berl); 2024 Jul; 102(7):947-959. PubMed ID: 38780771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-PanIN-seq unveils that
    Liu S; Cao W; Niu Y; Luo J; Zhao Y; Hu Z; Zong C
    Elife; 2021 May; 10():. PubMed ID: 33983114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas.
    Todoric J; Antonucci L; Di Caro G; Li N; Wu X; Lytle NK; Dhar D; Banerjee S; Fagman JB; Browne CD; Umemura A; Valasek MA; Kessler H; Tarin D; Goggins M; Reya T; Diaz-Meco M; Moscat J; Karin M
    Cancer Cell; 2017 Dec; 32(6):824-839.e8. PubMed ID: 29153842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis.
    Sigafoos AN; Tolosa EJ; Carr RM; Fernandez-Barrena MG; Almada LL; Pease DR; Hogenson TL; Raja Arul GL; Mousavi F; Sen S; Vera RE; Marks DL; Flores LF; LaRue-Nolan KC; Wu C; Bamlet WR; Vrabel AM; Sicotte H; Schenk EL; Smyrk TC; Zhang L; Rabe KG; Oberg AL; Zaphiropoulos PG; Chevet E; Graham RP; Hagen CE; di Magliano MP; Elsawa SF; Pin CL; Mao J; McWilliams RR; Fernandez-Zapico ME
    Cancer Res Commun; 2024 Jul; 4(7):1677-1689. PubMed ID: 38896052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancer.
    Cortesi A; Gandolfi F; Arco F; Di Chiaro P; Valli E; Polletti S; Noberini R; Gualdrini F; Attanasio S; Citron F; Ho IL; Shah R; Yen EY; Spinella MC; Ronzoni S; Rodighiero S; Mitro N; Bonaldi T; Ghisletti S; Monticelli S; Viale A; Diaferia GR; Natoli G
    Sci Adv; 2024 Mar; 10(13):eadk5386. PubMed ID: 38536927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.